25.90
-2.26%
Close of 2 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medicamen Organics
Its shares trade on NSE under the ticker MEDIORG.NS. It has been listed since 28 June 2024. In the fiscal year to 31 March 2025, it reported revenue of ₹381.9m and net income of ₹40.5m. At that date it held total assets of ₹592.1m and shareholders' equity of ₹301.3m.
Medicamen Organics Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in New Delhi, Delhi. The company went IPO on 2024-06-28. Medicamen Organics Limited is an India-based pharmaceutical company. The firm is engaged in developing, manufacturing and distribution of a range of pharmaceutical dosages, including generic dosage in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspension and dry powders for governments (including both state and central governments) and private institutions as contract manufacturer/third party manufacturer. Its product portfolio consists of over 84 products and comprises a range of drugs such as antibacterial, anti-diarrheal, antifungal, anti-malarial, anti-diabetic, proton pump inhibitor, antihistamine, antihypertensive drugs, anti-lipidemic drug, antiparasitic, multivitamin, multimineral and non-steroidal anti-inflammatory drug (NSAIDS). Its products are marketed across India as well as African, CIS and southeast Asian Countries, such as Congo, Benin, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 28 Jun 2024
- Employees
- 112
- Website
- medicamenorganics.com ↗
Leadership
Pay as last reported
- Mr. Bal GuptaExecutive Chairman of the Board, Managing Director, since 1995₹1.3m
- Mr. Lalit GuptaChief Financial Officer₹780,000
- Ms. Varsha BansalCompany Secretary & Compliance Officer₹163,000
- Mr. Brijesh ChaubeyExecutive Director, since 2024
- Mr. Ashutosh GuptaWhole Time Director, since 2004₹780,000
- Ms. Sneh GaurNon-Executive Director₹50,000
- Mr. Rajinder GuptaNon-Executive Independent Director₹10,000
- Mr. Sachin GuptaNon-Executive Independent Director₹10,000
- Mr. Rakesh KumarNon-Executive Independent Director₹10,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Medicamen Organics Ltd employs 112 full-time staff members in India.
- The firm manufactures over 84 pharmaceutical products for global markets.
- It supplies generic dosages to governments and private institutions as a contract manufacturer.
Weaknesses
- The company operates from a single headquarters in New Delhi.
- It relies on third-party manufacturing for its extensive product portfolio.
- Listing occurred recently on 28 June 2024, limiting long-term track record data.
Opportunities
- Expansion into African countries like Congo, Benin, and Senegal offers new revenue streams.
- Selling to CIS nations such as Kyrgyzstan and Burundi increases market reach.
- Distributing to southeast Asian countries like the Philippines and Myanmar grows sales volume.
Threats
- Regulatory changes in India could impact the manufacturing of generic dosages.
- Competition in the pharmaceutical sector may reduce profit margins for contract manufacturing.
- Economic instability in target markets like Mozambique and Myanmar affects distribution reliability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.